Masumi Ai

Summary

Affiliation: Tufts University
Country: USA

Publications

  1. ncbi Paraoxonase (PON1) is associated with familial combined hyperlipidemia
    Thomas M van Himbergen
    Department of Clinical Chemistry and Haematology, UMC Utrecht, Utrecht, The Netherlands
    Atherosclerosis 199:87-94. 2008
  2. ncbi Familial combined hyperlipidemia is associated with alterations in the cholesterol synthesis pathway
    Thomas M van Himbergen
    Lipid Metabolism Laboratory, Tufts University, 711 Washington Street, Boston, MA 02111 1524, USA
    Arterioscler Thromb Vasc Biol 30:113-20. 2010
  3. ncbi Comparison of the effects of maximal dose atorvastatin and rosuvastatin therapy on cholesterol synthesis and absorption markers
    Thomas M van Himbergen
    Lipid Metabolism Laboratory, Human Nutrition Research Center on Aging at Tufts University, Boston, MA, USA
    J Lipid Res 50:730-9. 2009
  4. ncbi Paraoxonase (PON1) and the risk for coronary heart disease and myocardial infarction in a general population of Dutch women
    Thomas M van Himbergen
    Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht, The Netherlands
    Atherosclerosis 199:408-14. 2008
  5. ncbi Effects of intensive atorvastatin and rosuvastatin treatment on apolipoprotein B-48 and remnant lipoprotein cholesterol levels
    Seiko Otokozawa
    Cardiovascular Research Laboratory, Friedman School of Nutrition Science and Policy at Tufts University and Tufts University School of Medicine, Boston, MA 02111, USA
    Atherosclerosis 205:197-201. 2009
  6. ncbi Effects of maximal atorvastatin and rosuvastatin treatment on markers of glucose homeostasis and inflammation
    Nuntakorn Thongtang
    Jean Mayer United States Department of Agriculture, Human Nutrition Research Center on Aging, Tufts University, Boston, Massachusetts, USA
    Am J Cardiol 107:387-92. 2011
  7. ncbi Adiponectin: an independent risk factor for coronary heart disease in men in the Framingham offspring Study
    Masumi Ai
    Lipid Metabolism Laboratory, Human Nutrition Research Center on Aging at Tufts University, Boston, MA 02111, USA
    Atherosclerosis 217:543-8. 2011
  8. ncbi Biomarkers for insulin resistance and inflammation and the risk for all-cause dementia and alzheimer disease: results from the Framingham Heart Study
    Thomas M van Himbergen
    Lipid Metabolism Laboratory, Human Nutrition Research Center on Aging, Tufts University, Boston, MA 02111, USA
    Arch Neurol 69:594-600. 2012
  9. ncbi Fasting and postprandial apolipoprotein B-48 levels in healthy, obese, and hyperlipidemic subjects
    Seiko Otokozawa
    Lipid Metabolism Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, Boston, MA 02111, USA
    Metabolism 58:1536-42. 2009
  10. ncbi Direct assessment of plasma low density lipoprotein and high density lipoprotein cholesterol levels and coronary heart disease: results from the Framingham Offspring Study
    Seiko Otokozawa
    Lipid Metabolism Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, 711 Washington Street, Boston, MA 02111, USA
    Atherosclerosis 213:251-5. 2010

Collaborators

Detail Information

Publications16

  1. ncbi Paraoxonase (PON1) is associated with familial combined hyperlipidemia
    Thomas M van Himbergen
    Department of Clinical Chemistry and Haematology, UMC Utrecht, Utrecht, The Netherlands
    Atherosclerosis 199:87-94. 2008
    ..0 (95% CI, 1.3-19.1, P=0.02)). In conclusion, in this population of subjects from well-defined families with FCH, PON1 is biochemically and genetically associated with FCH...
  2. ncbi Familial combined hyperlipidemia is associated with alterations in the cholesterol synthesis pathway
    Thomas M van Himbergen
    Lipid Metabolism Laboratory, Tufts University, 711 Washington Street, Boston, MA 02111 1524, USA
    Arterioscler Thromb Vasc Biol 30:113-20. 2010
    ..In light of prior metabolic and genetic research, our purpose was to ascertain whether FCH cases had significant abnormalities of plasma markers of cholesterol synthesis and absorption as compared to unaffected kindred members...
  3. ncbi Comparison of the effects of maximal dose atorvastatin and rosuvastatin therapy on cholesterol synthesis and absorption markers
    Thomas M van Himbergen
    Lipid Metabolism Laboratory, Human Nutrition Research Center on Aging at Tufts University, Boston, MA, USA
    J Lipid Res 50:730-9. 2009
    ..In addition, alterations in absolute values of plasma sterols correlated with the cholesterol lowering response...
  4. ncbi Paraoxonase (PON1) and the risk for coronary heart disease and myocardial infarction in a general population of Dutch women
    Thomas M van Himbergen
    Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht, The Netherlands
    Atherosclerosis 199:408-14. 2008
    ..3-69.5, P < 0.0001, multivariate model). In conclusion, this study shows that in middle-aged women paraoxonase activity was associated with an increased risk for AMI and that the risk was modified by the effects of smoking...
  5. ncbi Effects of intensive atorvastatin and rosuvastatin treatment on apolipoprotein B-48 and remnant lipoprotein cholesterol levels
    Seiko Otokozawa
    Cardiovascular Research Laboratory, Friedman School of Nutrition Science and Policy at Tufts University and Tufts University School of Medicine, Boston, MA 02111, USA
    Atherosclerosis 205:197-201. 2009
    ..Our findings utilizing a specific immunoassay and a fairly large number of subjects extend prior studies indicating that statins significantly lower apolipoprotein B containing lipoproteins of both intestinal and liver origin...
  6. ncbi Effects of maximal atorvastatin and rosuvastatin treatment on markers of glucose homeostasis and inflammation
    Nuntakorn Thongtang
    Jean Mayer United States Department of Agriculture, Human Nutrition Research Center on Aging, Tufts University, Boston, Massachusetts, USA
    Am J Cardiol 107:387-92. 2011
    ..5% vs -4.9%, p = 0.15). In conclusion, our data have indicated that the maximum dosage of atorvastatin or rosuvastatin therapy significantly lower C-reactive protein levels but also moderately increase insulin levels...
  7. ncbi Adiponectin: an independent risk factor for coronary heart disease in men in the Framingham offspring Study
    Masumi Ai
    Lipid Metabolism Laboratory, Human Nutrition Research Center on Aging at Tufts University, Boston, MA 02111, USA
    Atherosclerosis 217:543-8. 2011
    ..Our aim was to determine whether plasma adiponectin levels were an independent predictor of coronary heart disease (CHD) risk...
  8. ncbi Biomarkers for insulin resistance and inflammation and the risk for all-cause dementia and alzheimer disease: results from the Framingham Heart Study
    Thomas M van Himbergen
    Lipid Metabolism Laboratory, Human Nutrition Research Center on Aging, Tufts University, Boston, MA 02111, USA
    Arch Neurol 69:594-600. 2012
    ....
  9. ncbi Fasting and postprandial apolipoprotein B-48 levels in healthy, obese, and hyperlipidemic subjects
    Seiko Otokozawa
    Lipid Metabolism Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, Boston, MA 02111, USA
    Metabolism 58:1536-42. 2009
    ..Median apo B-48 values in healthy subjects are about 0.5 mg/dL and increase more than 100% in the fed state. Elevated levels are observed in obese and hyperlipidemic subjects...
  10. ncbi Direct assessment of plasma low density lipoprotein and high density lipoprotein cholesterol levels and coronary heart disease: results from the Framingham Offspring Study
    Seiko Otokozawa
    Lipid Metabolism Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, 711 Washington Street, Boston, MA 02111, USA
    Atherosclerosis 213:251-5. 2010
    ..We evaluated direct low density lipoprotein (LDL) cholesterol (C) and high density lipoprotein (HDL) cholesterol (C) versus standard methods using fasting plasma samples from participants in cycle 6 of the Framingham Offspring Study...
  11. ncbi Effects of maximal doses of atorvastatin versus rosuvastatin on small dense low-density lipoprotein cholesterol levels
    Masumi Ai
    Cardiovascular Research Laboratory, Friedman School of Nutrition Science and Policy at Tufts University, Boston, Massachusetts, USA
    Am J Cardiol 101:315-8. 2008
    ....
  12. ncbi Effects of weight loss, induced by gastric bypass surgery, on HDL remodeling in obese women
    Bela F Asztalos
    Lipid Metabolism Laboratory, Human Nutrition Research Center at Tufts University, Boston, MA, USA
    J Lipid Res 51:2405-12. 2010
    ..05) concentrations. These results demonstrate beneficial changes in HDL remodeling following substantial weight loss induced by RYGBP surgery and that these changes are associated with improvement of glucose homeostasis in these patients...
  13. ncbi Small dense LDL cholesterol and coronary heart disease: results from the Framingham Offspring Study
    Masumi Ai
    Lipid Metabolism Laboratory, Human Nutrition Research Center on Aging at Tufts University, Boston, MA 02111, USA
    Clin Chem 56:967-76. 2010
    ..We sought to establish reference values for a new direct assay for small dense LDL cholesterol (sdLDL-C) and to measure sdLDL-C concentrations in patients with established coronary heart disease (CHD) vs controls...
  14. ncbi Extended-release niacin alters the metabolism of plasma apolipoprotein (Apo) A-I and ApoB-containing lipoproteins
    Stefania Lamon-Fava
    Lipid Metabolism Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, Boston, MA 02111, USA
    Arterioscler Thromb Vasc Biol 28:1672-8. 2008
    ..Extended-release niacin effectively lowers plasma TG levels and raises plasma high-density lipoprotein (HDL) cholesterol levels, but the mechanisms responsible for these effects are unclear...
  15. ncbi Glycated albumin and direct low density lipoprotein cholesterol levels in type 2 diabetes mellitus
    Masumi Ai
    Lipid Metabolism Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, Boston, MA 02111, USA
    Clin Chim Acta 406:71-4. 2009
    ....
  16. ncbi Altering dietary lysine:arginine ratio has little effect on cardiovascular risk factors and vascular reactivity in moderately hypercholesterolemic adults
    Sonia Vega-Lopez
    Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, Boston, MA 02111, USA
    Atherosclerosis 210:555-62. 2010
    ..Information is scarce regarding the effect of dietary protein type, with specific focus on the lysine-to-arginine (Lys:Arg) ratio, on cardiovascular risk factors and vascular reactivity in humans...